Haruka Yoshida
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
APC/PIK3CA mutations and β-catenin status predict tankyrase inhibitor sensitivity of patient-derived colorectal cancer cells.
Journal: British journal of cancer
Published: December 11, 2022
Neutralization of the induced VEGF-A potentiates the therapeutic effect of an anti-VEGFR2 antibody on gastric cancer in vivo.
Journal: Scientific reports
Published: February 10, 2021
Epigenetic and transcriptional regulation of osteoclast differentiation.
Journal: Bone
Published: May 31, 2020
Design and Discovery of an Orally Efficacious Spiroindolinone-Based Tankyrase Inhibitor for the Treatment of Colon Cancer.
Journal: Journal of medicinal chemistry
Published: March 24, 2020
Discovery of Novel Spiroindoline Derivatives as Selective Tankyrase Inhibitors.
Journal: Journal of medicinal chemistry
Published: March 19, 2019
Targeting glioma stem cells in vivo by a G-quadruplex-stabilizing synthetic macrocyclic hexaoxazole.
Targeting glioma stem cells in vivo by a G-quadruplex-stabilizing synthetic macrocyclic hexaoxazole.
Journal: Scientific reports
Published: February 08, 2017
APC Mutations as a Potential Biomarker for Sensitivity to Tankyrase Inhibitors in Colorectal Cancer.
APC Mutations as a Potential Biomarker for Sensitivity to Tankyrase Inhibitors in Colorectal Cancer.
Journal: Molecular cancer therapeutics
Published: August 30, 2016
mTOR signaling mediates resistance to tankyrase inhibitors in Wnt-driven colorectal cancer.
Journal: Oncotarget
Published: August 26, 2016
TRF1 ensures the centromeric function of Aurora-B and proper chromosome segregation.
Journal: Molecular and cellular biology
Published: April 23, 2014
Showing 1-12 of 12
Last Updated: 09/26/2026